1. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies. Issue 10383 (8th April 2023) Authors: Sandborn, William J; Vermeire, Séverine; Peyrin-Biroulet, Laurent; Dubinsky, Marla C; Panes, Julian; Yarur, Andres; Ritter, Timothy; Baert, Filip; Schreiber, Stefan; Sloan, Sheldon; Cataldi, Fabio; Shan, Kevin; Rabbat, Christopher J; Chiorean, Michael; Wolf, Douglas C; Sands, Bruce E; D'Haens, Ge... Journal: Lancet Issue: Volume 401:Issue 10383(2023) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Exploring the physiologic role of human gastroesophageal reflux by analyzing time‐series data from 24‐h gastric and esophageal pH recordings. Issue 7 (17th July 2014) Authors: Lu, Luo; Mu, John C.; Sloan, Sheldon; Miner, Philip B.; Gardner, Jerry D. Journal: Physiological reports Issue: Volume 2:Issue 7(2014:Jul.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Indirect Treatment Comparison of Ustekinumab Versus Other Biologics in Moderate‐to‐Severe Crohn's Disease Patients Having Failed Anti‐TNF Therapy: A 1‐Year Treatment Sequence Analysis Including Delayed Responders: 708. (October 2017) Authors: Mesana, Laura; Pacou, Maud; Naessens, Dominik; Sloan, Sheldon; Gauthier, Aline Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Indirect Treatment Comparison of Ustekinumab versus Other Biologics in Moderate‐to‐Severe Crohn's Disease Patients Having Failed Conventional Therapy: A 1‐Year Treatment Sequence Analysis Including Delayed Responders: 709. (October 2017) Authors: Mesana, Laura; Pacou, Maud; Naessens, Dominik; Sloan, Sheldon; Gauthier, Aline Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Opioid Use in Patients With Inflammatory Bowel Disease. Issue 1 (14th February 2020) Authors: Lin, Xiwu; Lofland, Jennifer; Zhang, Ling; Sloan, Sheldon; Chamaa, Laila; Marano, Colleen; Plevy, Scott Journal: Crohn's & colitis 360 Issue: Volume 2:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P049 COMPARISON OF USTEKINUMAB CONCENTRATION ASSAYS AND ANTIBODIES-TO-USTEKINUMAB ASSAYS. (7th February 2019) Authors: Marini, Joseph C; Chun, Kelly Y; Rebarchak, Shannon; Dogmanits, Shannon; Sloan, Sheldon; Shankar, Gopi Journal: Inflammatory bowel diseases Issue: Volume 25(2019)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Response and Remission After 16 Weeks of Ustekinumab: An All Patients Analysis From the UNITI Crohn's Studies: 718. (October 2017) Authors: Colombel, Jean‐Frederic; Sloan, Sheldon; Gasink, Christopher; Gao, Long Long; Jacobstein, Douglas; Lee, Scott D.; Targan, Stephan R. Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. S734 Etrasimod 2mg Once Daily as Treatment for Patients With Moderately to Severely Active Ulcerative Colitis: Topline and Subgroup Analysis From ELEVATE UC 52 and ELEVATE UC 12. (October 2022) Authors: Peyrin-Biroulet, Laurent; Sandborn, William J.; D'Haens, Geert; Panés, Julian; Yarur, Andres; Wolf, Douglas C.; Ritter, Timothy E.; Schreiber, Stefan; Sloan, Sheldon; Cataldi, Fabio; Shan, Kevin; Rabbat, Christopher J.; Chiorean, Michael; Baert, Filip; Sands, Bruce E.; Dubinsky, Marla C.; Vermeir... Other Names: Feagan Brian G. presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e516 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. S900 Real World Treatment (Tx) Patterns and Healthcare Costs Among U.S. Commercially Insured Adults Initiating Biologics for Ulcerative Colitis (UC). (October 2021) Authors: Wolf, Douglas C.; Puckett, Justin; Setyawan, Juliana; Rabbat, Christopher; Sloan, Sheldon; Kamal-Bahl, Sachin Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1 Page Start: S424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Tolerability of Ustekinumab in Induction and Maintenance for the Treatment of Crohn's Disease: 658. (October 2017) Authors: Loftus, Edward V.; Sattin, Bernie; Jacobstein, Douglas; Gasink, Christopher; Sloan, Sheldon; Feagan, Brian G.; Colombel, Jean‐Frederic Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗